Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Kamal Mahtani has been appointed chair of one of the HTA Programme’s five advisory committees. The Primary Care Topic Identification, Development and Evaluation (TIDE) panel advises on the research agenda for the HTA programme based on the needs of NHS primary care.

The NIHR is the research arm of the NHS - the HTA Programme is its biggest research programme and assesses around 600 research funding applications every year.

The advisory panels have two roles:

  • Support the identification and development of potential research questions to be put to the research community as calls for research in the programme’s commissioned workstream.
  • Evaluate and prioritise first stage research applications to the HTA’s researcher led work stream based on the importance of research questions to the NHS and whether a proposed study would make a significant difference to practice.

Kamal Mahtani is an Oxford-based GP and Deputy Director of the Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences. He has been the deputy chair of the TIDE panel since 2015 and will take over as Chair from Professor Clare Wilkinson in early 2018.

Commenting on the appointment, Kamal said “There are currently many challenges facing those working in and served by NHS primary care. My focus will be to support the NIHR HTA programme in identifying and funding research that seeks to meet some of these challenges.”

Story adapted with permission from NIHR School for Primary Care Research.